BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33235787)

  • 1. Massive pheochromocytoma.
    Anai T; Oka K; Yokota Y; Nishimura Y; Hagiya H; Otsuka F
    Clin Case Rep; 2020 Nov; 8(11):2308-2309. PubMed ID: 33235787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of pheochromocytoma using [123I]-compared with [131I]-metaiodobenzylguanidine scintigraphy.
    Furuta N; Kiyota H; Yoshigoe F; Hasegawa N; Ohishi Y
    Int J Urol; 1999 Mar; 6(3):119-24. PubMed ID: 10226821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False-positive 123I-metaiodobenzylguanidine scintigraphy in a patient with a gastrointestinal stromal tumor presenting as a left adrenal incidentaloma.
    Sugito E; Tanabe A; Maruyama K; Nohara K; Enomoto N; Bouchi R; Ohsugi M; Ueki K; Yamada K; Kajio H
    Endocrinol Diabetes Metab Case Rep; 2023 Feb; 2023(1):. PubMed ID: 36815698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic localization of extra-adrenal pheochromocytoma: comparison of (123)I-MIBG imaging and (131)I-MIBG imaging.
    Nakatani T; Hayama T; Uchida J; Nakamura K; Takemoto Y; Sugimura K
    Oncol Rep; 2002; 9(6):1225-7. PubMed ID: 12375024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical use and utility of metaiodobenzylguanidine scintigraphy in pheochromocytoma diagnosis.
    Lev I; Kelekar G; Waxman A; Yu R
    Endocr Pract; 2010; 16(3):398-407. PubMed ID: 20061293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal cardiac sympathetic nerve function in a patient with pheochromocytoma. An analysis using 123I metaiodobenzylguanidine scintigraphy.
    Izumi C; Himura Y; Konishi T
    Int J Cardiol; 1995 Jun; 50(2):189-92. PubMed ID: 7591331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. False-positive 123I-metaiodobenzylguanidine (MIBG) scan in a patient with angiomyolipoma; positive MIBG scan does not necessarily indicate the presence of pheochromocytoma.
    Takasu N; Hayashi M; Takara M; Iha T; Kouki T; Ohshiro Y; Ogawa Y
    Intern Med; 2007; 46(20):1717-21. PubMed ID: 17938527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of neural crest tumors by 123I-MIBG scintigraphy].
    Ikekubo K; Hino M; Ootsuka H; Ito H; Yamaguchi H; Dan Y; Masui Y; Bito S; Ohta K; Saiki Y
    Kaku Igaku; 1994 Nov; 31(11):1357-64. PubMed ID: 7837704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The efficacy of early 123I-MIBG scintigraphy for pheochromocytoma diagnosis].
    Ishikawa N; Takeda T; Wu J; Echigo J; Itai Y
    Kaku Igaku; 1995 Jul; 32(7):659-65. PubMed ID: 7674577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and localization of pheochromocytoma.
    Goldstein DS; Eisenhofer G; Flynn JA; Wand G; Pacak K
    Hypertension; 2004 May; 43(5):907-10. PubMed ID: 15023935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete remission of metastatic pheochromocytoma in
    Sugino T; Ando R; Unno R; Iida K; Naiki T; Hamamoto S; Mizuno K; Okada A; Umemoto Y; Kawai N; Tozawa K; Hayashi Y; Inaki A; Kayano D; Kinuya S; Yasui T
    BMC Res Notes; 2017 Dec; 10(1):750. PubMed ID: 29258609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Noninvasive screening for pheochromocytoma in patients with an incidentally discovered adrenal mass: usefulness of provocative test with metoclopramide and 131I-metaiodobenzylguanidine scintigraphy].
    Yokoyama H; Tsuji Y
    Hinyokika Kiyo; 1999 Oct; 45(10):677-80. PubMed ID: 10586357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of 123I-MIBG Scintigraphy on Clinical Decision-Making in Pheochromocytoma and Paraganglioma.
    Rao D; van Berkel A; Piscaer I; Young WF; Gruber L; Deutschbein T; Fassnacht M; Beuschlein F; Spyroglou A; Prejbisz A; Hanus K; Eisenhofer G; Manelli M; Canu L; Lenders JWM; Bancos I; Timmers HJLM
    J Clin Endocrinol Metab; 2019 Sep; 104(9):3812-3820. PubMed ID: 30822354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of pheochromocytoma associated with neurofibromatosis type 1].
    Kobayashi H; Kaneko G; Nishimoto K; Uchida A
    Hinyokika Kiyo; 2009 Dec; 55(12):749-52. PubMed ID: 20048558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epinephrine producing pheochromocytoma. Is the secretory pattern decisive for the clinical manifestation?
    Lipsic E; Balazovjech I; Kosmálová V; Makaiová I; Dekrét J; Zanou DF
    J Endocrinol Invest; 2004; 27(7):691-4. PubMed ID: 15505997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [123I-metaiodobenzylguanidine myocardial scintigraphy in a case of pheochromocytoma before and after resection of it].
    Matsumoto K; Sugihara H; Ito K; Terada K; Taniguchi Y; Ohtsuki K; Nakata T; Ushijima Y; Maeda T; Nakagawa M
    Kaku Igaku; 1995 Sep; 32(9):1023-8. PubMed ID: 8523838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Location of adrenal medullary pheochromocytoma by I-123 metaiodobenzylguanidine SPECT.
    Nielsen JT; Nielsen BV; Rehling M
    Clin Nucl Med; 1996 Sep; 21(9):695-9. PubMed ID: 8879869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine 131-labeled metaiodobenzylguanidine scintigraphy and biochemical analyses in suspected pheochromocytoma.
    Hanson MW; Feldman JM; Beam CA; Leight GS; Coleman RE
    Arch Intern Med; 1991 Jul; 151(7):1397-402. PubMed ID: 2064491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pitfalls in the diagnosis and treatment of a hypertensive patient with unilateral primary aldosteronism and contralateral pheochromocytoma: a case report.
    Miyamoto S; Yoshida Y; Ozeki Y; Okamoto M; Gotoh K; Masaki T; Nishida H; Fujinami H; Shin T; Daa T; Asayama Y; Shibata H
    BMC Endocr Disord; 2023 Feb; 23(1):44. PubMed ID: 36797699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.